Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report(vol 14, 1372295, 2024

被引:0
作者
Castelli, Barbara [1 ,2 ]
Fonte, Carla [2 ]
Guidi, Milena [1 ,2 ]
Tellini, Marco [2 ]
Di Nicola, Marco [2 ]
Iacono, Alessandro [3 ]
Buccoliero, Anna Maria [4 ]
Greto, Daniela [5 ]
Genitori, Lorenzo [6 ]
Sardi, Iacopo [2 ]
机构
[1] Univ Florence, Hlth Sci Dept, Florence, Italy
[2] Meyer Childrens Hosp IRCCS, Neurooncol Unit, Florence, Italy
[3] Meyer Childrens Hosp IRCCS, Radiol Unit, Florence, Italy
[4] Meyer Childrens Hosp IRCCS, Pathol Unit, Florence, Italy
[5] Univ Florence, Radiotherapy Unit, Florence, Italy
[6] Meyer Childrens Hosp IRCCS, Neurosurg Unit, Florence, Italy
关键词
low-grade gliomas; bevacizumab; irinotecan; pilocytic astrocytoma; case report;
D O I
10.3389/fonc.2024.1372295
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 1 条
[1]   Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report [J].
Castelli, Barbara ;
Fonte, Carla ;
Guidi, Milena ;
Tellini, Marco ;
Di Nicola, Marco ;
Iacono, Alessandro ;
Buccoliero, Anna Maria ;
Greto, Daniela ;
Genitori, Lorenzo ;
Sardi, Iacopo .
FRONTIERS IN ONCOLOGY, 2023, 13